title: Reevaluating PSA Testing Rates in the PLCO Trial.
authors.affiliation: New York Presbyterian Hospital, New York, NY jes9171@nyp.org.
authors.forename: Jonathan E
authors.initials: JE
authors.lastname: Shoag
authors.affiliation: New York Presbyterian Hospital, New York, NY jes9171@nyp.org.
authors.forename: Sameer
authors.initials: S
authors.lastname: Mittal
authors.affiliation: Weill Cornell Medical College, New York, NY.
authors.forename: Jim C
authors.initials: JC
authors.lastname: Hu
mesh_terms: D051517:Digital Rectal Examination; D055088:Early Detection of Cancer / Q000191:economics / Q000592:standards*; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D016032:Randomized Controlled Trials as Topic; D014481:United States
chemical_list: D017430:Prostate-Specific Antigen